Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

It’s Time to Study Palantir and Nio: My Best and Worst Picks in 2020

With 2020 coming to an end, here's how PLTR and NIO stock calls have performed this year. And what it means for investing in 2021.

ACB Stock: Why Aurora Cannabis Shares Are Climbing Higher Today

An upbeat business update, paired with news of a pot-rivals tie-up has Aurora Cannabis shares up in pre-market trading. Is this the catalyst that ACB stock needs?

BIDU Stock: 11 Things to Know About Baidu and Its Big EV News

BIDU stock continues to drive higher on news that Baidu could soon be making its own electric vehicles. Here's why that matters.

Tilray Stock: TLRY and Aphria Stock Soar on Cannabis Merger News

Tilray stock and Aphria stock are soaring on news that the two cannabis companies will form one, trading as TLRY stock.

Plug Power Stock Continues to Build a War Chest for Growth

Plug Power raised $1 billion in a bought deal recently. As it builds a war chest, what does this mean for Plug Power stock heading into 2021? 

Sundial Growers Stock Faces More Complications

Though the political winds are moving favorably for Sundial Growers stock, the more important concern may be the economy.

A Smarter Trade to Make After Last Week’s Hot IPOs

Unless you’re a thrill-seeking risk-junkie, tech IPOs are probably not the best way to take advantage of the Technochasm. Here's a better place to look.

Gevo Stock Deserves a Spot in Your Zero-Carbon Holdings

Ready for the revolution in renewable energy sources? If so, then super-cheap GEVO stock offers access to a firm with rock-solid financials.

Wait for CIIG Merger Stock to Cool Off

CIIC stock has soared since the merger with Arrival was announced. While the story is intriguing, the rally seems to have gone too far.

Novavax Stock Leads the Board on Wall Street but Lags on Main Street

NVAX stock is up over 3,000% this year yet it's not the one with the doses on the streets. Best to trade the stock while they chase the headline.

AMWL Stock: Why Telemedicine Play Amwell Is Plunging Today

AMWL stock is plunging Tuesday without any real news from telemedicine play Amwell. Here's one potential reason for the big move.

Expect Nvidia Stock to Hold Steady As We Head Into 2021

Despite many factors on its side, the valuation of Nvidia stock remains stretched at current prices, limiting the potential for more gains.

Wait for Nio Stock to Fall Before Buying It

Nio stock is an expensive but excellent investment. Buy more shares shortly before its earnings or delivery announcements.

7 Under-the-Radar Breakout Stocks for 2021

With so much hype baked into the market, smart speculators may want to consider these under-the-radar breakout stocks for 2021.

Investor Day Shows Why Starbucks Stock Will Keep Marching Higher

Starbucks took a hit during the pandemic. But Investor Day shows the company is going back on offense, which makes Starbucks stock a buy.

ANCN Stock: Why Anchiano Therapeutics Stock Is Blasting Higher Today

Anchiano Therapeutics (ANCN) stock is soaring higher on Tuesday following news of a merger with Chemomab that will bring major changes.

eVTOL News: Experience Investment (EXPC) Stock Gets a Lift From Blade SPAC Merger News

News of a merger between eVTOL company Blade and SPAC company Experience Investment (EXPC) has EXPC stock on the rise Tuesday.

Now On Sale, Kaixin Auto Stock Is a Worthy Lottery Ticket Investment

Admittedly, KXIN stock isn't for everyone. Traders will have to expect volatility, but the stock's cheaper now and could pop at any moment.

OCX Stock: Why Shares of Biotech OncoCyte Are Skyrocketing Today

Shares of OCX stock are blasting off on Tuesday morning after a major company agreement with an important China-based biotech firm.